PHXM Annual ROE
-0.95%
+245.14%+99.61%
31 December 2022
Summary:
As of February 3, 2025, PHXM annual return on equity is -0.95%, with the most recent change of +245.14% (+99.61%) on December 31, 2022. During the last 3 years, it has risen by +72.24% (+98.70%).PHXM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Quarterly ROE
-0.39%
-3.13%-114.23%
30 September 2023
Summary:
As of February 3, 2025, PHXM quarterly return on equity is -0.39%, with the most recent change of -3.13% (-114.23%) on September 30, 2023. Over the past year, it has increased by +3.22% (+89.20%).PHXM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.6% | +89.2% |
| 3 y3 years | +98.7% | +89.2% |
| 5 y5 years | +94.6% | +89.2% |
PHXM ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -101.8% | -114.2% |
PHAXIAM Therapeutics SA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -0.39%(-114.2%) |
| June 2023 | - | 2.74%(-175.9%) |
| Dec 2022 | -0.95%(-99.6%) | -3.61%(-95.7%) |
| Sept 2022 | - | -84.84%(-34.3%) |
| June 2022 | - | -129.04%(-28.9%) |
| Mar 2022 | - | -181.37%(-1.6%) |
| Dec 2021 | -246.09%(-4.0%) | -184.35%(-4.5%) |
| Sept 2021 | - | -193.12%(-7.2%) |
| June 2021 | - | -208.05%(+19.0%) |
| Mar 2021 | - | -174.90%(-6.0%) |
| Dec 2020 | -256.45% | -186.03%(+74.4%) |
| Sept 2020 | - | -106.66%(+25.8%) |
| June 2020 | - | -84.81%(+27.2%) |
| Mar 2020 | - | -66.70%(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | - | -61.31%(+44.8%) |
| Dec 2019 | -73.19%(+170.1%) | - |
| Sept 2019 | - | -42.34%(+14.8%) |
| June 2019 | - | -36.88%(+85.1%) |
| Mar 2019 | - | -19.92%(+59.7%) |
| Dec 2018 | - | -12.47%(+104.4%) |
| Dec 2018 | -27.10%(+55.3%) | - |
| Sept 2018 | - | -6.10% |
| Dec 2017 | -17.45%(-72.9%) | - |
| Dec 2016 | -64.37%(+99.1%) | - |
| Dec 2015 | -32.33%(+19.5%) | - |
| Dec 2014 | -27.05%(-53.1%) | - |
| Dec 2013 | -57.66%(-210.0%) | - |
| Dec 2012 | 52.43% | - |
FAQ
- What is PHAXIAM Therapeutics SA annual return on equity?
- What is the all time high annual ROE for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual ROE year-on-year change?
- What is PHAXIAM Therapeutics SA quarterly return on equity?
- What is the all time high quarterly ROE for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA quarterly ROE year-on-year change?
What is PHAXIAM Therapeutics SA annual return on equity?
The current annual ROE of PHXM is -0.95%
What is the all time high annual ROE for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual return on equity is 52.43%
What is PHAXIAM Therapeutics SA annual ROE year-on-year change?
Over the past year, PHXM annual return on equity has changed by +245.14% (+99.61%)
What is PHAXIAM Therapeutics SA quarterly return on equity?
The current quarterly ROE of PHXM is -0.39%
What is the all time high quarterly ROE for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly return on equity is 2.74%
What is PHAXIAM Therapeutics SA quarterly ROE year-on-year change?
Over the past year, PHXM quarterly return on equity has changed by +3.22% (+89.20%)